Healthcare -
Biotechnology - NASDAQ - US
$ 13.455
-7.07 %
$ 1.6 B
Market Cap
-12.34
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Arcutis Biotherapeutics, Inc.
| Revenue | 197 M |
| Cost Of Revenue | 19.1 M |
| Gross Profit | 177 M |
| Operating Expenses | 306 M |
| Operating Income | -128 M |
| Other Expenses | 11.6 M |
| Net Income | -140 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 196.5 | 59.6 | 3.7 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 19.1 | 5.0 | 0.8 | 0.8 | 0.5 | 0.2 | 0 | 0 |
| Gross Profit | 177.4 | 54.6 | 2.9 | (0.8) | (0.5) | (0.2) | 0 | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 305.8 | 295.7 | 304.6 | 206.5 | 136.6 | 43.1 | 19.7 | 4.1 |
| Selling, General and Administrative Expenses | 229.4 | 185.1 | 122.1 | 61.0 | 21.3 | 6.6 | 1.8 | 0.7 |
| Research and Development Expenses | 76.4 | 110.6 | 182.4 | 145.6 | 115.3 | 36.5 | 17.9 | 3.4 |
| Operating Income | (128.4) | (241.1) | (301.6) | (206.5) | (136.6) | (43.1) | (19.7) | (4.1) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 27.2 | 29.7 | 15.7 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (11.0) | (17.9) | (9.8) | 0.2 | 1.0 | 1.1 | 0.5 | (0.9) |
| Pre-Tax Income | (139.4) | (259.0) | (311.5) | (206.4) | (135.7) | (42.0) | (19.3) | (5.0) |
| NET INCOME | ||||||||
| Tax Provision | 0.6 | 3.1 | 9.8 | (0.5) | 84.3 K | 23.1 K | (0.5) | (4.1) |
| Net Income | (140.0) | (262.1) | (321.3) | (205.9) | (135.7) | (42.0) | (19.3) | (5.0) |
| EPS | 1.16 | 3.78 | 5.84 | 4.17 | 3.8 | 1.1 | 0.531 | 0.137 |